TY  - GEN
AU  - Khalafallah,A A
AU  - Slancar,M
AU  - Cosolo,W
AU  - Abdi,E
AU  - Chern,B
AU  - Woodfield,R J
AU  - Copeman,M C
TI  - Long-term safety of monthly zoledronic acid therapy beyond 1 year in patients with advanced cancer involving bone (LoTESS): A multicentre prospective phase 4 study
SN  - 1365-2354
PY  - 2018///0907
KW  - Aged
KW  - Aged, 80 and over
KW  - Bone Density Conservation Agents
KW  - adverse effects
KW  - Bone Diseases
KW  - drug therapy
KW  - Diphosphonates
KW  - Female
KW  - Humans
KW  - Imidazoles
KW  - Kaplan-Meier Estimate
KW  - Longitudinal Studies
KW  - Male
KW  - Middle Aged
KW  - Neoplasms
KW  - complications
KW  - Prospective Studies
KW  - Zoledronic Acid
N1  - Publication Type: Clinical Trial, Phase IV; Journal Article; Multicenter Study; Observational Study
UR  - https://doi.org/10.1111/ecc.12638
ER  -